Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.40 |
| ▸ | GABRE | P78334 | 1/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.40 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29669953 | 1.00 | KDM4E (0.59) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| Ethane SCHEMBL28184948 | 0.98 | KDM4E (0.58) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| Hexane SCHEMBL28184950 | 0.91 | KDM4E (0.50) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL21990971 | 0.86 | KDM4E (0.42) | KDM4EKMT2AMEN1GPR35HTT | |
| SCHEMBL19125812 | 0.86 | KDM4E (0.42) | KDM4ETDP1TTRALB | |
| SCHEMBL31432230 | 0.86 | KDM4E (0.42) | KDM4ETDP1TTRALB | |
| SCHEMBL6263161 | 0.81 | NOTUM (0.41) | KDM4ENOTUMKMT2AMEN1TDP1 | |
| SCHEMBL25300437 | 0.81 | KDM4E (0.39) | KDM4EGPR35HTTTTRALB | |
| SCHEMBL14645844 | 0.81 | ALDH1A1 (0.49) | KDM4EGPR35 | |
| SCHEMBL635493 | 0.81 | KDM4E (0.39) | KDM4EGPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112920277-B | VHH-ELISA kit for analyzing cyantraniliprole and chlorantraniliprole residues and application thereof | 中国农业大学 | 2022-08-09 | — | — | CN | claimed |
| EP-2729444-B1 | METHOD FOR MANUFACTURING 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER IP GMBH (DE) | 2017-08-23 | — | — | EP | claimed |
| US-9169198-B2 | Method for the production of 2-amino-5-cyano-N,3-dimethylbenzamide | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-10-27 | — | — | US | claimed |
| US-20140148611-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-29 | — | — | US | claimed |
| WO-2026099847-A1 | SYNTHESIS OF CYANO-ANTHRANILIC ACID | ADAMA MAKHTESHIM LTD. (IL) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026099847-A1 | SYNTHESIS OF CYANO-ANTHRANILIC ACID | ADAMA MAKHTESHIM LTD. (IL) | 2026-05-15 | — | — | WO | disclosed |
| US-12331028-B2 | Process for preparation of Anthranilamides | UPL LTD (IN) | 2025-06-17 | — | — | US | disclosed |
| EP-3902792-B1 | PROCESS FOR PREPARATION OF ANTHRANILAMIDES | UPL LTD (IN) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025049326-A1 | TRICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | BIOCRYST PHARMACEUTICALS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-119431187-A | Preparation method of key intermediate of chlorantraniliprole | 山东垄喜植物保护有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-12221436-B2 | Anthranilamides, their use as insecticide and processes for preparing the same | PI INDUSTRIES LTD. (IN) | 2025-02-11 | — | — | US | disclosed |
| US-20240327395-A1 | A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS | TAGROS CHEMICALS INDIA PVT LTD (IN) | 2024-10-03 | — | — | US | disclosed |
| WO-2007043677-A1 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-19 | — | — | WO | disclosed |
| EP-1771070-A1 | MIXTURES OF ANTHRANILAMIDE INVERTEBRATE PEST CONTROL AGENTS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-04-11 | — | — | EP | disclosed |
| EP-1751112-A2 | ANTHRANILAMIDE INSECTICIDES | E.I.Du pont de nemours and company (US) | 2007-02-14 | — | — | EP | disclosed |
| WO-2006068669-A1 | MIXTURES OF ANTHRANILAMIDE INVERTEBRATE PEST CONTROL AGENTS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006023783-A1 | NOVEL ANTHRANILAMIDES USEFUL FOR CONTROLLING INVERTEBRATE PESTS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-03-02 | — | — | WO | disclosed |
| WO-2005118552-A2 | ANTHRANILAMIDE INSECTICIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | disclosed |
| WO-2004018414-A2 | ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | KDM4E 2637/4885GABRP 3873/4885GABRD 2221/4885 |
| US-20140148611-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | ALKBH5, ALKBH2, MMAB | KDM4E 124/4885GABRP 1406/4885GABRD 1068/4885 |
| US-12221436-B2 | Anthranilamides, their use as insecticide and processes for preparing the same | CYP1A2, ANTXR2, DDT | KDM4E 1143/4885GABRP 2497/4885GABRD 2391/4885 |
| US-20240327395-A1 | A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS | XDH, PDHX, CYP11B1 | KDM4E 1398/4885GABRP 516/4885GABRD 428/4885 |
| US-12331028-B2 | Process for preparation of Anthranilamides | NAAA, ANTXR2, AADAC | KDM4E 898/4885GABRP 3165/4885GABRD 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.